MADS30 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
MADS30 antibody; Os06g0667200 antibody; LOC_Os06g45650 antibody; P0637D03.37MADS-box transcription factor 30 antibody; OsMADS30 antibody
Target Names
MADS30
Uniprot No.

Target Background

Function
This antibody targets a protein that is likely a transcription factor.
Database Links
Subcellular Location
Nucleus.
Tissue Specificity
Ubiquitous.

Q&A

What is the MADS30 protein and what experimental applications would require MADS30 antibodies?

MADS30 belongs to the MADS-box family of transcription factors, specifically within the Bsis subclade in cereals alongside MADS29 and MADS31 . These transcription factors play critical roles in plant reproductive development, with MADS30 being implicated in female germline development and nucellar patterning similar to its family member MADS31 .

MADS30 antibodies are essential research tools for:

  • Tracking protein expression patterns across developmental stages

  • Chromatin immunoprecipitation (ChIP) experiments to identify DNA binding sites

  • Co-immunoprecipitation studies to discover protein interaction partners

  • Immunohistochemistry to visualize tissue and cellular localization

  • Western blotting to quantify protein expression levels

How are monoclonal antibodies against plant transcription factors like MADS30 typically generated?

Generation of monoclonal antibodies against plant transcription factors typically follows this methodology:

  • Antigen preparation: Recombinant expression of full-length MADS30 protein or specific peptide fragments, typically using bacterial expression systems with appropriate tags for purification .

  • Immunization protocol:

    • Mice or rabbits are immunized with the purified MADS30 protein/peptide

    • Multiple booster immunizations at 2-3 week intervals

    • Titer testing of serum to confirm immune response

  • Hybridoma development:

    • Harvest B lymphocytes from immunized animals

    • Fuse B cells with myeloma cells using polyethylene glycol to create hybridomas

    • Screen hybridoma supernatants against MADS30 antigen using ELISA

  • Selection and cloning:

    • Positive colonies are expanded and subcloned to ensure monoclonality

    • Antibody-producing clones are characterized for specificity, affinity, and cross-reactivity

  • Production and purification:

    • Scale-up of hybridoma cultures

    • Purification of antibodies using protein A/G chromatography

    • Quality control testing for purity and activity

What validation methods should be employed to confirm MADS30 antibody specificity?

Comprehensive validation is critical for ensuring experimental reproducibility and reliability:

Validation MethodProcedureControlsExpected Outcome
Western blotSDS-PAGE of plant extracts followed by immunoblotting1. Wild-type tissue
2. mads30 mutant tissue
3. Recombinant MADS30
Single band at predicted MW (23-25 kDa) in WT; absent in mutant
ImmunoprecipitationPull-down from plant extracts followed by mass spectrometry1. MADS30 antibody
2. Isotype control antibody
Enrichment of MADS30 peptides only in specific antibody sample
ImmunohistochemistryTissue fixation, sectioning, and antibody staining1. Primary antibody omission
2. Pre-immune serum
3. mads30 mutant tissue
Signal in expected tissues for WT; minimal background in controls
Peptide competitionPre-incubation of antibody with immunizing peptide1. Without competing peptide
2. With non-specific peptide
Signal ablation only with specific peptide
Cross-reactivity testingTesting against related MADS-box proteinsRecombinant MADS29, MADS31Minimal or no binding to homologous proteins

Similar validation approaches to those used for MADS31 antibodies should be applied, particularly focusing on distinguishing between the closely related Bsis subclade members .

What are the optimal conditions for MADS30 antibody use in chromatin immunoprecipitation (ChIP) experiments?

Optimizing ChIP experiments with MADS30 antibodies requires careful consideration of several parameters:

Crosslinking parameters:

  • Use 1% formaldehyde for 10-15 minutes at room temperature

  • For transient DNA-protein interactions, consider dual crosslinking with DSG (disuccinimidyl glutarate) prior to formaldehyde

  • Quench with 0.125M glycine for 5 minutes

Sonication conditions:

  • Fragment chromatin to 200-500bp using optimized sonication cycles

  • Verify fragmentation efficiency via agarose gel electrophoresis

  • For plant tissues, extended sonication may be required due to cell wall components

Immunoprecipitation protocol:

  • Pre-clear chromatin with protein A/G beads and non-specific IgG

  • Use 2-5μg of MADS30 antibody per ChIP reaction

  • Include mock IP (no antibody) and IgG controls

  • Incubate overnight at 4°C with rotation

  • Wash stringently to reduce background (adjust salt and detergent concentrations based on pilot experiments)

Verification strategies:

  • Perform qPCR on known targets (based on MADS-box consensus binding sites CArG motifs)

  • Compare enrichment patterns with MADS29 and MADS31 ChIP data to identify unique and shared targets

  • Consider the position of CArG motifs (MADS-box binding sites) when designing primers

Results should demonstrate enrichment of genomic regions containing CArG motifs [CC(A/T)₆GG], similar to those identified for related MADS-box proteins .

How can researchers use MADS30 antibodies to investigate protein-protein interactions with other MADS-box proteins?

MADS-box proteins typically function through the formation of protein complexes. The following methodological approaches are recommended:

Co-immunoprecipitation (Co-IP):

  • Prepare protein extracts under non-denaturing conditions (phosphate or Tris buffer pH 7.4, 150mM NaCl, 0.1-0.5% NP-40/Triton X-100)

  • Immobilize 2-5μg MADS30 antibody on protein A/G beads

  • Incubate with protein extract overnight at 4°C

  • Wash with buffer containing reduced detergent

  • Elute and analyze by western blot with antibodies against suspected interacting partners

Proximity Ligation Assay (PLA):

  • Fix and permeabilize plant tissues

  • Incubate with MADS30 antibody and antibody against potential interacting protein

  • Apply species-specific PLA probes with complementary oligonucleotides

  • Ligate and amplify signal if proteins are in close proximity (<40nm)

  • Visualize and quantify interaction signals

Bimolecular Fluorescence Complementation validation:

  • Follow up antibody-based discoveries with BiFC using split fluorescent proteins fused to MADS30 and interacting partners

Research findings suggest that MADS-box proteins like MADS31 can form complexes with other family members, including MADS29 . Based on this homology, MADS30 should be investigated for potential interactions with MADS29 and MADS31, particularly in reproductive tissue development contexts.

What technical considerations are important when interpreting MADS30 protein levels detected by antibodies versus mRNA expression data?

Researchers must consider several factors when reconciling protein and transcript data:

ConsiderationTechnical ImpactInterpretation Guidelines
Post-transcriptional regulationmRNA levels may not correlate with protein abundanceCompare temporal patterns rather than absolute values
Protein stabilityMADS30 may have tissue-specific stability profilesMeasure protein half-life in different tissues using cycloheximide chase experiments
Antibody sensitivity limitsWestern blotting may have higher detection thresholds than qRT-PCRConsider enrichment steps for low-abundance samples
Spatial resolution differencesIn situ hybridization and immunohistochemistry may have different sensitivitiesPerform both techniques on serial sections for direct comparison
Epitope maskingProtein-protein interactions may mask antibody binding sitesUse multiple antibodies targeting different MADS30 epitopes

A study on MADS31 revealed that protein localization data obtained through immunolabeling provided crucial information about inner nucellus identity that complemented mRNA in situ hybridization . Similar approaches should be applied to MADS30, particularly examining expression in reproductive tissues where MADS-box proteins play crucial developmental roles.

How can MADS30 antibodies be used to investigate the impact of environmental stresses on protein expression and localization?

Environmental stresses can significantly alter transcription factor expression and function. Methodological approaches for studying MADS30 under stress conditions include:

Protein expression quantification:

  • Expose plants to relevant stresses (drought, heat, salinity, pathogens)

  • Harvest tissues at defined time points

  • Perform western blot analysis with MADS30 antibodies

  • Normalize to appropriate loading controls

  • Quantify relative expression changes

Subcellular localization shifts:

  • Perform nuclear/cytoplasmic fractionation followed by immunoblotting

  • Alternatively, use immunofluorescence microscopy to track localization

  • Measure nuclear/cytoplasmic signal ratios across stress conditions

Post-translational modifications:

  • Use phospho-specific antibodies if available

  • Alternatively, perform immunoprecipitation followed by mass spectrometry

  • Look for mobility shifts in western blots that might indicate modifications

Research on related MADS-box proteins suggests these transcription factors can act as stress response regulators . MADS31 has been shown to repress stress-related genes in normal conditions , and MADS30 may have similar regulatory functions that can be investigated using these antibody-based approaches.

What are the most common technical challenges when using MADS30 antibodies, and how can they be addressed?

ChallengePossible CausesRecommended Solutions
High background in immunohistochemistryNon-specific binding1. Increase blocking (5% BSA/milk)
2. Reduce antibody concentration
3. Include 0.1-0.3% Triton X-100 in washes
4. Pre-absorb antibody with plant extract
Weak or no signal in western blotsLow protein abundance or poor extraction1. Enrich nuclear proteins
2. Use plant-optimized extraction buffers with protease inhibitors
3. Reduce washing stringency
4. Increase antibody concentration or incubation time
Multiple bands in western blotCross-reactivity with related MADS proteins1. Use peptide competition controls
2. Compare with mads30 mutant extracts
3. Consider using monoclonal antibodies with higher specificity
4. Pre-absorb antibody with recombinant related proteins
Poor ChIP enrichmentInefficient crosslinking or epitope inaccessibility1. Optimize crosslinking conditions
2. Test different sonication protocols
3. Use alternative antibodies targeting different epitopes
4. Consider native ChIP if formaldehyde interferes with epitope
Inconsistent immunoprecipitation resultsBuffer incompatibility1. Test different buffer compositions
2. Vary salt concentration (150-300mM)
3. Try different detergents (NP-40, Triton X-100, Tween-20)
4. Add BSA (0.1-0.5%) to reduce non-specific binding

Based on experiences with other plant transcription factor antibodies, adding 0.1-0.5% plant-specific protease inhibitors and performing all extractions at 4°C is critical for preserving MADS30 integrity during experiments.

How can researchers distinguish between closely related MADS-box family members using antibody-based approaches?

Distinguishing between MADS29, MADS30, and MADS31 proteins requires careful experimental design:

Epitope selection strategy:

  • Choose antibody epitopes from divergent regions (typically N-terminal domains or C-terminal regions outside the conserved MADS-box)

  • Avoid the highly conserved MADS domain and K domain when possible

  • Perform sequence alignment analysis to identify unique peptide regions

Validation approaches:

  • Test antibody reactivity against recombinant MADS29, MADS30, and MADS31 proteins

  • Perform western blots on extracts from single, double, and triple mutants if available

  • Use peptide competition assays with specific and cross-reactive peptides

Combined methods for confirmation:

  • Complement antibody detection with transcript-specific methods (RNA-seq, qRT-PCR)

  • Perform mass spectrometry on immunoprecipitated samples to confirm protein identity

  • Create epitope-tagged transgenic lines for each MADS protein as validation controls

Research into MADS-box proteins has shown that they can have distinct expression patterns despite high sequence similarity . Thus, careful validation is essential to ensure antibody specificity, particularly when studying closely related family members like the Bsis subclade.

How might next-generation antibody technologies improve MADS30 research?

Emerging technologies are poised to enhance the quality and application of antibodies in plant transcription factor research:

Nanobodies (single-domain antibodies):

  • Smaller size allows better tissue penetration

  • Can reach epitopes inaccessible to conventional antibodies

  • Potential for improved specificity for MADS30 over related family members

  • Enhanced stability under various experimental conditions

Recombinant antibody engineering:

  • Custom-designed antibodies with specific affinity properties

  • Humanized or fully synthetic antibodies with reduced background

  • Engineering Fc modifications to enhance stability similar to therapeutic antibodies

  • Production in plant expression systems for higher compatibility

Antibody-enzyme fusion proteins:

  • Proximity-dependent labeling using antibody-peroxidase fusions

  • Antibody-APEX2 fusions for electron microscopy visualization

  • Antibody-BirA fusions for proximity-dependent biotinylation to identify MADS30 interactors

Future research using these technologies could provide unprecedented insights into MADS30 function, similar to how antibody engineering has revolutionized therapeutic applications .

What roles might MADS30 antibodies play in understanding evolutionary conservation of plant reproductive development?

MADS30 antibodies can serve as valuable tools for comparative evolutionary studies:

Cross-species applications:

  • Test MADS30 antibody cross-reactivity across related cereal species

  • Compare expression patterns in primitive versus advanced plant lineages

  • Investigate conservation of protein-protein interactions across species

Functional conservation assessment:

  • Use antibodies to compare subcellular localization in diverse species

  • Examine post-translational modifications across evolutionary diversity

  • Compare ChIP-seq profiles to assess conservation of DNA binding targets

Evolutionary biology applications:

  • Investigate neo-functionalization events through comparative immunoprecipitation

  • Study subfunctionalization by comparing expression domains across species

  • Trace evolutionary relationships based on epitope conservation

Research on MADS-box proteins has revealed their crucial roles in plant evolution, particularly in reproductive development . MADS30 antibodies could help elucidate how this specific family member has contributed to the diversification of reproductive structures across plant lineages.

What community resources are available for researchers working with MADS30 antibodies?

Researchers can access various resources to support their MADS30 antibody work:

Antibody repositories and databases:

  • The Arabidopsis Biological Resource Center (ABRC)

  • Plant Antibody Database

  • Developmental Studies Hybridoma Bank

  • CiteAb for literature-based antibody citations

Validation resources:

  • The Antibody Registry for unique research resource identifiers (RRIDs)

  • Antibody Validation Database

  • Plant Reactivity Database

Methodological guidance:

  • Plant Methods journal for specialized protocols

  • The Plant Cell's antibody validation guidelines

  • International Plant Molecular Biology protocols

Community forums:

  • Plant Scientists Network

  • Plantae.org forums

  • ResearchGate plant science community

These resources can help researchers identify validated antibodies and standardized protocols, ultimately improving experimental reproducibility in MADS30 research.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.